We do not manage diseases.
We reverse them.
Leveraging a platform technology to develop therapeutics targeting damaged elastin fiber, rendering calcified tissue and organs supple again.
We will help millions of people – every year.
1 of every 3 adults suffer from cardiovascular disease, but only about half of the people have their condition under control. In 2019, an estimated 17.9 million people died due to this issue, representing 32% of all global deaths. 85% of these deaths were due to heart attacks and strokes.
1 of every 3 adults have high blood pressure, but only about half (54%) of the people have their condition under control. The higher the pressure in blood vessels, the harder the heart has to work in order to pump blood. If left uncontrolled, hypertension can lead to a heart attack, enlargement of the heart and heart failure.
Elastin fibers are critical for the homeostasis of tissues around the body, including the skin, vasculature, and pulmonary tissues. As elastin fibers become damaged over time, arterial walls weaken, and the body’s physiological response results in aortic wall stiffening, aneurysms, and hypertension.
Our research speaks for itself.
Our proprietary platform selectively deliver drugs to damaged elastin. We already have proof of concept in cardiovascular calcification, aneurysms and emphysema animal models.